Analysis of the XRCC1 gene as a modifier of the cerebral response in ischemic stroke

BMC Medical Genetics

Volumn 7, Issue , 2006, Pages

  Dutra, Ana V C ^a   Lin, Hsiu Fen ^b,c   Juo, Suh Hang H ^b,c,d   Mohrenweiser, Harvey ^e   Sen, Souvik ^f   Grewal, Raji P ^a  

^a New Jersey Neuroscience Institute   (United States)

^b KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PYRIMIDINE NUCLEOTIDE; UNCLASSIFIED DRUG; X RAY REPAIR CROSS COMPLEMENTING GROUP 1 PROTEIN;

AGED; ARTICLE; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN VENTRICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DNA REPAIR; FEMALE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MODULATION; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; REGRESSION ANALYSIS; RISK FACTOR; STATISTICAL SIGNIFICANCE; STUDENT T TEST;

BRAIN ISCHEMIA; CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE;

EID: 34547139809     PISSN: 14712350     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-7-78     Document Type: Article

References (33)

1. Gorelick PB, Sacco RL, Smith DB, Smith M, Alberts L, Mustone-Alexander L, Rader D, Ross JL, Raps E, Ozer MN, Brass LM, Malone ME, Goldberg S, Booss J, Hanley DF, Toole JF, Greengold NL, Rhew DC: Prevention of a first stroke: a review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA 1999, 281:24-33.
2. Taylor TN, Davis PH, Torner JC, Holmes J, Meyer JW, Jacobson MF: Lifetime cost of stroke in the United States. Stroke 1996, 27:1459-66.
3. Murray CJ, Lopez AD: Alternative projections of mortality and disability by cause 1990-2020: GlobaL burden of Disease Study. Lancet 1997, 349:1498-1504.
4. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronall nitric oxide synthase. Science 1994, 265:1883-1885.
5. Harper AJ: Production of transgenic and mutant mouse models. Methods Mol Med 2005, 104:185-202.
6. Lovblad KO, Baird AE, Schlaug G, Benfield A, Siewert B, Voetsch B, Connor A, Burzynski C, Edelman RR, Warach S: Ischemic lesion volumes in acute stroke by diffusion-weighted magnetic resonance imaging correlate with clinical outcome. Ann Neurol 1997, 42:164-170.
7. Baird AE, Dambrosia J, Janket S, Eichbaum Q, Chaves C, Silver B, Barber PA, Parsons M, Darby D, Davis S: A three-item scale for the early prediction of stroke recovery. Lancet 2001, 357:2095-2099.
8. De Keyser J, Sulter G, Luiten PG: Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? Trends Neurosci 1999, 22:535-540.
9. Morita-Fujimura Y, Fujimura M, Yoshimoto T, Chan PH: Superoxide during reperfusion contributes to caspase-8 expression and apoptosis after transient focal stroke. Stroke 2001, 32:2356-2361.
10. Gursoy-Ozdemir Y, Can A, Dalkara T: Reperfusion-induced oxidative/ nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 2004, 35:1449-1453.
11. Liu PK: DNA damage and repair in the brain after cerebral ischemia. Curr Top Med Chem 2001, 1:483-495.
12. Sugawara T, Chan PH: Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid Redox Signal 2003, 5:597-607.
13. Liu PK: Ischemia-reperfusion-related repair deficit after oxidative stress implications of faulty transcripts in neuronal sensitivity after brain injury. J Biomed Sci 2003, 10:4-14.
14. Moore N, Okocha F, Cui JK, Liu PK: Homogeneous repair of nuclear genes after experimental stroke. J Neurochem 2002, 80:111-118.
15. Wood RD, Mitchell M, Sgouros J, Lindahl T: Human DNA repair genes. Science 2001, 291:1284-1289.
16. Vidal AE, Boiteux S, Hickson ID, Radicella JP: XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J 2001, 20:6530-6539.
17. Wang Y, Spitz MR, Zhu Y, Dong Q, Shete S, Wu X: From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. DNA Repair (Amst) 2003, 2:901-908.
18. Yoo H, Li L, Sacks PG, Thompson LH, Becker FF, Chan JY: Alterations in expression and structure of the DNA repair gene XRCC1. Biochem Biophys Res Commun 1992, 186:900-910.
19. Mohrenweiser HW, Wilson DM 3, Jones IM: Challenges and complexities in estimating both the functional impact and the disease risk associated with the extensive genetic variation in human DNA repair genes. Mutat Res 2003, 526:93-125.
20. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993, 24:35-41.
21. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C: Classsification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991, 337:1521-1526.
22. Kissela B, Broderick J, Woo D, Kothari R, Miller R, Khoury J, Brott T, Pancioli A, Jauch E, Gebel J, Shukla R, Alwell K, Tomsick T: Greater Cincinnati/Northern Kentucky steoke study: volume of first-ever ischemic stroke among blacks in a population-based study. Stroke 2001, 32:1285-1290.
23. Mohrenweiser HW, Xi T, Vazquez-Matias J, Jones I: Identification of 127 amino acid substitution variants in screening 37 DNA repair genes in humans. Cancer Epidemiol Biomark Prevent 2002, 11:1054-1066.
24. Nickerson DA, Tobe VO, Taylor SL: PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucl Acids Res 1997, 25:2745-2751.
25. Collins FS, Brooks LD, Chakravarti A: A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 1998, 8:1229-1231.
26. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD: Amino acid substitutions variants of APE1 and XRCC1 genes associated with loizing radiation sensitivity. Carcinogenesis 2001, 22:917-922.
27. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
28. Stephens M, Smith NJ, Donnelly R. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001, 68:978-989.
29. Ladiges W, Wiley J, MacAuley A: Polymorphisms in the DNA repair gene XRCC1 and age-related disease. Mechanisms of Ageing and Development 2003, 124:27-32.
30. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, Hall J: Polymorphism in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 2003, 12:1168-1174.
31. Masson MC, Niedergang V, Schreiber S, Muller J, de Murcia Menissier, de Murcia G: XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 1998, 18:3563-3571.
32. Cappelli E, Taylor R, Cevasco M, Abbondandolo A, Caldecott K, Frosina G: Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. The Journal of Biological Chemistry 1997, 272:23970-23975.
33. Cui J, Holmes EH, Greene TG, Liu PK: Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 2000, 14:955-967.